Cellular mechanisms in the development of atherosclerosis 1

Diabetes Research and Clinical Practice

Volumn 30, Issue SUPPL. 1, 1996, Pages S1-

  Rosenfeld, Michael E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Foam cells; Inflammation; Macrophages; Oxidized lipids

Indexed keywords

INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CONFERENCE PAPER; HUMAN; INFLAMMATION; LIPID METABOLISM;

ANIMALS; ARTERIOSCLEROSIS; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL DIVISION; CONNECTIVE TISSUE; FOAM CELLS; HUMANS; LEUKOCYTES; MACROPHAGES; MALE; MONOCYTES; NECROSIS; RABBITS;

EID: 85058199986     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)80032-5     Document Type: Article

References (68)

1. The role of the monocytc in atherogenesis I. Transition of blood-borne monocytcs into foam cells in fatty lesions
2. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation
3. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbits
4. Fatty streak initiation in WHHL and comparably hypercholesterolemic fat-fed rabbits
5. Cellularity of atherosclerotic lesions
6. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis
7. Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans
8. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits
9. Gene expression in atherosclerotic lesions
10. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl-LDL receptor mRNA colocalize with oxidation specific lipid-protein adducts
11. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
12. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of LDL, and contain oxidation specific lipid-protein adducts
13. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
14. Lactic dehydrogenase activity in blood
15. HHF-35, A muscle-actin-specific monoclonal antibody
16. Monoclonal antibodies to rabbit lymphoid cells: Preparation and characterization of a T-cell specific antibody
17. Differentiation antigens identify subpopulations of rabbit T and B lymphocytes. Definition by flow cytometry
18. The distribution and chemical composition of ultracentrifugally spearated lipoproteins in human serum
19. Oxidative modification of beta-very low density lipoprotein: potential role in monocyte recruitment and foam cell formation
20. A simple fluorometric assay for lipoperoxide in blood plasma
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Interleukin-I acts on cultured human vascular endothelium to increase adhesion of polymorphonuclear leukocytes monocytes and related leukocyte cells lines
23. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol diesters
24. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
25. Vascular cell adhesion molecule-I is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
26. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques
27. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-KB mobilization and induction of vascular cell adhesion molecule-I in endothelial cells stimulated to generate radicals
28. Initiation of atherosclerotic lesions in cholesterol-fed rabbits: I. Focal increases in arterial LDL concentration precede development of fatty streak lesions
29. Initiation of atherosclerotic lesion in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries
30. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes
31. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
32. Minimally modified low density lipoprotein is biologically active in vivo in mice
33. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein
34. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages
35. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocytes-macrophages
36. Beyond cholesterol Modifications of low-density lipoprotein that increase its atherogenicity
37. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor
38. Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages
39. Cocxpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions
40. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor related protein and scavenger receptor in human atherosclerotic lesions
41. Lipid A binding sites in membranes of macrophage tumor cell
42. Expression cloning of SR-BI a CD36-related class B scavenger receptor
43. Synthesis of IL-I alpha and IL-I beta by arterial cells in athcrosclerosis
44. Macrophage colony-stimulating factor mRNA and protein in atherosclcrotic lesions of rabbits and man
45. Induction of interleukin-I-beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadeca-dienoic acid
46. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins
47. Secretory products of macrophages
48. Detection and localization of tumor necrosis factor in human atheroma
49. Complement receptors in atherosclerotic lesions
50. Components of the protein fraction of oxidized ion density lipoprotein stimulate interleukin-lα production by rabbit arterial macrophage-derived foam cells
51. Immune mechanisms in atherosclerosis
52. Macrophage foam cells containing oxidation specific epitopes simultaneously express scavenger receptors and HLA-DR antigens in human atherosclerotic plaques
53. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries
54. Why do plaques rupture?
55. Monocytes and neutrophils oxidized low density lipoproteins making it cytotoxie
56. Triggering signaling cascades by receptor tyrosine kinases
57. G proteins
58. Signal integration at the level of protein kinases, protein phosphatases and their substrates
59. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation
60. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit